Ann Caroline Williams (Ann C Williams)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

British journal of cancer

EMBO molecular medicine

Nature

Exploration of targeted anti-tumor therapy

University of Bristol

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bristol Aug 01 2013

United Kingdom

Professor of Experimental Oncology :: Cellular and Molecular Medicine

University of Bristol

United Kingdom

Reader in Experimental Oncology :: Cellular and Molecular Medicine

University of Bristol

United Kingdom

Senior Lecturer :: Cellular and Molecular Medicine

University of Bristol

United Kingdom

Lecturer :: Pathology and Microbiology

University of Bristol

United Kingdom

Research fellow (University of Bristol) :: Pathology and Microbiology

University of Bristol

United Kingdom

Post-doctoral Research Assistant/Associate :: Pathology and Microbiology

King's College London School of Medicine, (St Thomas Hospital)

United Kingdom

Postdoctoral Research Assistant

Education History

University of Bristol

United Kingdom

PHD :: Biochemistry

University of Bristol

United Kingdom

BSC :: Biochamistry

Publications

Sandra Montes-Olivas, Danny Nigel Legge, Abbie Lund, Alexander G Fletcher, Ann Caroline Williams, Lucia Marucci, Martin Homer
In-silico and in-vitro morphometric analysis of intestinal organoids. PLoS computational biology 19 (8) (2023)
Ashley J Hoskin, Amy K Holt, Danny Nigel Legge, Tracey J Collard, Ann Caroline Williams, Emma E Vincent
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer. Exploration of targeted anti-tumor therapy 4 (4) (2023)
Steven William Dixon, Tracey Jane Collard, Eleanor May Harrisdotter Mortensson, Danny Nigel Legge, Adam Christian Chambers, Alexander Greenhough, Tom Julian Creed, Ann Caroline Williams
5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis. British journal of cancer 124 (12) (2021)
Dustin J Flanagan, Nalle Pentinmikko, Kalle Luopajärvi, Nicky J Willis, Kathryn Gilroy, Alexander P Raven, Lynn McGarry, Johanna I Englund, Anna T Webb, Sandra Scharaw, Nadia Nasreddin, Michael C Hodder, Rachel A Ridgway, Emma Minnee, Nathalie Sphyris, Ella Gilchrist, Arafath K Najumudeen, Beatrice Romagnolo, Christine Perret, Ann Caroline Williams, Hans Clevers, Pirjo Nummela, Marianne Lähde, Kari Alitalo, Ville Hietakangas, Ann Hedley, William Clark, Colin Nixon, Kristina Kirschner, Edith Yvonne Jones, Ari Ristimäki, Simon J Leedham, Paul V Fish, Jean-Paul Vincent, Pekka Katajisto, Owen James Sansom
NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594 (7863) (2021)
Alexander Greenhough, Clare Bagley, Kate J Heesom, David B Gurevich, David Gay, Mark Bond, Tracey J Collard, Chris Paraskeva, Paul Martin, Owen James Sansom, Karim T A Malik, Ann Caroline Williams
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO molecular medicine 10 (11) (2019)
Danny Nigel Legge, Alex P Shephard, Tracey J Collard, Alexander Greenhough, Adam C Chambers, Richard W Clarkson, Christos Paraskeva, Ann Caroline Williams
BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells. Disease models & mechanisms 12 (3) (2019)

Ann Caroline Williams.css-eqlu8i{font-size:small;padding-left:4px;} (Ann C Williams)

Publication Activity (10 Years)

Top Topics

Top Venues

Ann Caroline Williams (Ann C Williams)